A E Tyrer1, R D Levitan1, S Houle1, A A Wilson1, J N Nobrega1,2, P M Rusjan1, J H Meyer3. 1. CAMH Research Imaging Centre and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Departments of Psychiatry, Pharmacology and Toxicology, Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada. 2. Behavioural Neurobiology Laboratory and Campbell Family Mental Health Research Institute, Departments of Psychiatry, Pharmacology and Toxicology, and Psychology, University of Toronto, Toronto, ON, Canada. 3. CAMH Research Imaging Centre and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Departments of Psychiatry, Pharmacology and Toxicology, Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada. jeff.meyer@camhpet.ca.
Abstract
OBJECTIVE: To investigate the effects of light therapy on serotonin transporter binding (5-HTT BPND ), an index of 5-HTT levels, in the anterior cingulate and prefrontal cortices (ACC and PFC) during winter in seasonal affective disorder (SAD). 5-HTT BPND fluctuates seasonally to a greater extent in SAD relative to health. We hypothesized that in SAD, 5-HTT BPND would be reduced in the ACC and PFC following light therapy. METHODS: Eleven SAD participants underwent [11 C] DASB positron emission tomography (PET) scans to measure 5-HTT BPND before and after 2 weeks of daily morning light therapy. RESULTS: The primary finding was a main effect of treatment on 5-HTT BPND in the ACC and PFC (repeated-measures manova, F(2,9) = 6.82, P = 0.016). This effect was significant in the ACC (F(1,10) = 15.11 and P = 0.003, magnitude of decrease, 11.94%) and PFC (F(1,10) = 8.33, P = 0.016, magnitude of decrease, 9.13%). 5-HTT BPND also decreased in other regions assayed following light therapy (repeated-measures manova, F(4,7) = 8.54, P = 0.028) including the hippocampus, ventral striatum, dorsal putamen, thalamus and midbrain (F(1,10) = 8.02-36.94, P < 0.0001-0.018; magnitude -8.83% to -16.74%). CONCLUSIONS: These results demonstrate that light therapy reaches an important therapeutic target in the treatment of SAD and provide a basis for improvement of this treatment via application of [11 C]DASB PET.
OBJECTIVE: To investigate the effects of light therapy on serotonin transporter binding (5-HTT BPND ), an index of 5-HTT levels, in the anterior cingulate and prefrontal cortices (ACC and PFC) during winter in seasonal affective disorder (SAD). 5-HTT BPND fluctuates seasonally to a greater extent in SAD relative to health. We hypothesized that in SAD, 5-HTT BPND would be reduced in the ACC and PFC following light therapy. METHODS: Eleven SADparticipants underwent [11 C] DASB positron emission tomography (PET) scans to measure 5-HTT BPND before and after 2 weeks of daily morning light therapy. RESULTS: The primary finding was a main effect of treatment on 5-HTT BPND in the ACC and PFC (repeated-measures manova, F(2,9) = 6.82, P = 0.016). This effect was significant in the ACC (F(1,10) = 15.11 and P = 0.003, magnitude of decrease, 11.94%) and PFC (F(1,10) = 8.33, P = 0.016, magnitude of decrease, 9.13%). 5-HTT BPND also decreased in other regions assayed following light therapy (repeated-measures manova, F(4,7) = 8.54, P = 0.028) including the hippocampus, ventral striatum, dorsal putamen, thalamus and midbrain (F(1,10) = 8.02-36.94, P < 0.0001-0.018; magnitude -8.83% to -16.74%). CONCLUSIONS: These results demonstrate that light therapy reaches an important therapeutic target in the treatment of SAD and provide a basis for improvement of this treatment via application of [11 C]DASB PET.
Authors: Grazyna Rajkowska; Gouri Mahajan; Beata Legutko; Lavanya Challagundla; Michael Griswold; Paul R Albert; Mireille Daigle; Jose J Miguel-Hidalgo; Mark C Austin; Randy D Blakely; David C Steffens; Craig A Stockmeier Journal: Neuroscience Date: 2017-07-13 Impact factor: 3.590
Authors: Martin Nørgaard; Melanie Ganz; Claus Svarer; Vibe G Frokjaer; Douglas N Greve; Stephen C Strother; Gitte M Knudsen Journal: Neuroimage Date: 2019-06-01 Impact factor: 6.556
Authors: Raymond W Lam; Minnie Y Teng; Young-Eun Jung; Vanessa C Evans; John F Gottlieb; Trisha Chakrabarty; Erin E Michalak; Jill K Murphy; Lakshmi N Yatham; Dorothy K Sit Journal: Can J Psychiatry Date: 2019-12-12 Impact factor: 4.356
Authors: Eve Reynaud; Fabrice Berna; Emmanuel Haffen; Luisa Weiner; Julia Maruani; Michel Lejoyeux; Carmen M Schroder; Patrice Bourgin; Pierre A Geoffroy Journal: J Clin Med Date: 2021-04-27 Impact factor: 4.241
Authors: Lihua Sun; Jing Tang; Heidi Liljenbäck; Aake Honkaniemi; Jenni Virta; Janne Isojärvi; Tomi Karjalainen; Tatu Kantonen; Pirjo Nuutila; Jarmo Hietala; Valtteri Kaasinen; Kari Kalliokoski; Jussi Hirvonen; Harry Scheinin; Semi Helin; Kim Eerola; Eriika Savontaus; Emrah Yatkin; Juha O Rinne; Anne Roivainen; Lauri Nummenmaa Journal: J Neurosci Date: 2020-12-23 Impact factor: 6.167
Authors: Marie Spies; Gregory M James; Chrysoula Vraka; Cécile Philippe; Marius Hienert; Gregor Gryglewski; Arkadiusz Komorowski; Alexander Kautzky; Leo Silberbauer; Verena Pichler; Georg S Kranz; Lukas Nics; Theresa Balber; Pia Baldinger-Melich; Thomas Vanicek; Benjamin Spurny; Edda Winkler-Pjrek; Wolfgang Wadsak; Markus Mitterhauser; Marcus Hacker; Siegfried Kasper; Rupert Lanzenberger; Dietmar Winkler Journal: Transl Psychiatry Date: 2018-09-21 Impact factor: 6.222